The resumption of trading for Immix Biopharma shares (IMMX) is significant news for investors and traders, indicating that whatever issue caused the halt has been resolved. However, without specific details on the reasons behind the trading halt and resumption, it's challenging to predict the exact direction of the stock price. Typically, the resumption can lead to increased volatility as the market reacts to the news. Investors should watch for any further announcements from the company that could provide more context.